{"id":231662,"date":"2026-02-19T22:07:58","date_gmt":"2026-02-20T04:07:58","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/02\/complement-inhibition-for-acute-neuromyelitis-optica-spectrum-disorder-attacksinsights-from-an-international-case-series"},"modified":"2026-02-19T22:07:58","modified_gmt":"2026-02-20T04:07:58","slug":"complement-inhibition-for-acute-neuromyelitis-optica-spectrum-disorder-attacksinsights-from-an-international-case-series","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/02\/complement-inhibition-for-acute-neuromyelitis-optica-spectrum-disorder-attacksinsights-from-an-international-case-series","title":{"rendered":"Complement Inhibition for Acute Neuromyelitis Optica Spectrum Disorder AttacksInsights From an International Case Series"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/complement-inhibition-for-acute-neuromyelitis-optica-spectrum-disorder-attacksinsights-from-an-international-case-series2.jpg\"><\/a><\/p>\n<p>These findings underscore the potential role of complement inhibition as a treatment option for acute NMOSD attacks, particularly in patients with insufficient response to standard therapies.<\/p>\n<hr>\n<p>Background and Objectives.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>These findings underscore the potential role of complement inhibition as a treatment option for acute NMOSD attacks, particularly in patients with insufficient response to standard therapies. Background and Objectives.<\/p>\n","protected":false},"author":662,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-231662","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/231662","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/662"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=231662"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/231662\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=231662"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=231662"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=231662"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}